Pesquisas alternativas:
complex cases » complex causes (Expandir a Pesquisa), complex case (Expandir a Pesquisa), complex care (Expandir a Pesquisa)
load company » lead company (Expandir a Pesquisa), lncd company (Expandir a Pesquisa), good company (Expandir a Pesquisa)
bcl complex » bcl2 complex (Expandir a Pesquisa), cl complex (Expandir a Pesquisa), scl complex (Expandir a Pesquisa)
company car » company case (Expandir a Pesquisa), company a (Expandir a Pesquisa), company carlos (Expandir a Pesquisa)
can newts » can new (Expandir a Pesquisa), can newly (Expandir a Pesquisa)
cases non » causes non (Expandir a Pesquisa), case non (Expandir a Pesquisa), cases new (Expandir a Pesquisa)
com can » com cana (Expandir a Pesquisa), com cant (Expandir a Pesquisa), com cal (Expandir a Pesquisa)
3 load » i load (Expandir a Pesquisa), 3 loaded (Expandir a Pesquisa)
l com » l como (Expandir a Pesquisa), e com (Expandir a Pesquisa), l con (Expandir a Pesquisa)
car a » carr a (Expandir a Pesquisa), car _ (Expandir a Pesquisa), war a (Expandir a Pesquisa)
complex cases » complex causes (Expandir a Pesquisa), complex case (Expandir a Pesquisa), complex care (Expandir a Pesquisa)
load company » lead company (Expandir a Pesquisa), lncd company (Expandir a Pesquisa), good company (Expandir a Pesquisa)
bcl complex » bcl2 complex (Expandir a Pesquisa), cl complex (Expandir a Pesquisa), scl complex (Expandir a Pesquisa)
company car » company case (Expandir a Pesquisa), company a (Expandir a Pesquisa), company carlos (Expandir a Pesquisa)
can newts » can new (Expandir a Pesquisa), can newly (Expandir a Pesquisa)
cases non » causes non (Expandir a Pesquisa), case non (Expandir a Pesquisa), cases new (Expandir a Pesquisa)
com can » com cana (Expandir a Pesquisa), com cant (Expandir a Pesquisa), com cal (Expandir a Pesquisa)
3 load » i load (Expandir a Pesquisa), 3 loaded (Expandir a Pesquisa)
l com » l como (Expandir a Pesquisa), e com (Expandir a Pesquisa), l con (Expandir a Pesquisa)
car a » carr a (Expandir a Pesquisa), car _ (Expandir a Pesquisa), war a (Expandir a Pesquisa)
1
“... and proliferation index. More cases of low grade than high grade non-Hodgkin's lymphoma expressed bcl-2...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Melarangi, T, Zhuang, J, Lin, K, Rockliffe, N, Bosanquet, A G, Oates, M, Slupsky, J R, Pettitt, A R
Publicado em 2012
“... and Bak by upregulated Bim/Bcl-2 complexes, and that GC resistance results from the failure...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Borner, M M, Brousset, P, Pfanner-Meyer, B, Bacchi, M, Vonlanthen, S, Hotz, M A, Altermatt, H J, Schlaifer, D, Reed, J C, Betticher, D C
Publicado em 1999
“... for the antiapoptotic proteins Bcl-2 and Mcl-1 were present in 31% and 58% of the cases evaluated, respectively, whereas...”Publicado em 1999
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Nieters, Alexandra, Conde, Lucia, Slager, Susan L., Brooks-Wilson, Angela, Morton, Lindsay, Skibola, Danica R., Novak, Anne J., Riby, Jacques, Ansell, Stephen M., Halperin, Eran, Shanafelt, Tait D., Agana, Luz, Wang, Alice H., De Roos, Anneclaire J., Severson, Richard K., Cozen, Wendy, Spinelli, John, Butterbach, Katja, Becker, Nikolaus, de Sanjose, Silvia, Benavente, Yolanda, Cocco, Pierluigi, Staines, Anthony, Maynadié, Marc, Foretova, Lenka, Boffetta, Paolo, Brennan, Paul, Lan, Qing, Zhang, Yawei, Zheng, Tongzhang, Purdue, Mark, Armstrong, Bruce, Kricker, Anne, Vajdic, Claire M., Grulich, Andrew, Smith, Martyn T., Bracci, Paige M., Chanock, Stephen J., Hartge, Patricia, Cerhan, James R., Wang, Sophia S., Rothman, Nathaniel, Skibola, Christine F.
Publicado em 2012
“... complex class III region conferred a reduced risk of B-cell NHL (odds ratio = 0.68, P random = 1.07 × 10...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“...The interactions of three related cationic porphyrins, TMPyP4, TMPyP3 and TMPyP2, with a WT 39-mer...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Bischin, Alina M, Dorer, Russell, Aboulafia, David M
Publicado no Clin Med Insights Blood Disord (2017)
Assuntos:
“...Case Report...”Publicado no Clin Med Insights Blood Disord (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Heinze, Sten, Putnam, Daniel K., Fischer, Axel W., Kohlmann, Tim, Weiner, Brian E., Meiler, Jens
Publicado no Proteins (2015)
“...-based modeling (TBM) targets. BCL::Fold assembles the tertiary structure of a protein from predicted...”Publicado no Proteins (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Cardenas, Mariano G, Oswald, Erin, Yu, Wenbo, Xue, Fengtian, MacKerell, Alexander D., Melnick, Ari M.
Publicado no Clin Cancer Res (2016)
“...-corepressor complexes suggested that BCL6 might be a druggable target. Accordingly a number of compounds have...”Publicado no Clin Cancer Res (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Seok, Yoonmi, Kim, Juwon, Choi, Jong Rak, Kim, Yu Ri, Park, Seo-Jin, Kim, Sue Jung, Song, Jaewoo, Lee, Kyung-A
Publicado em 2012
Assuntos:
“...Case Report...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“... that of non-LIP cases: LIP versus IPF (mean difference, 95% confidence interval (CI)) 2.39 (1.54 to 3.24); LIP...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Melnick, Ari, Carlile, Graeme, Ahmad, K. Farid, Kiang, Chih-Li, Corcoran, Connie, Bardwell, Vivian, Prive, Gilbert G., Licht, Jonathan D.
Publicado em 2002
“... conserved N-terminal BTB (bric a brac, tramtrack, broad complex)/POZ domain of PLZF plays a critical role...”Publicado em 2002
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Yonetani, Noboru, Ueda, Chiyoko, Akasaka, Takashi, Nishikori, Momoko, Uchiyama, Takashi, Ohno, Hitoshi
Publicado no Jpn J Cancer Res (2001)
“..., the 5′‐BCL2 fused 3’of a Vλ, gene that was upstream of another Vλ/Jλ complex carrying a non‐producing...”Publicado no Jpn J Cancer Res (2001)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Azimian, Hosein, Bahreyni-Toossi, Mohammad Taghi, Rezaei, Abdul Rahim, Rafatpanah, Houshang, Hamzehloei, Tayebeh, Fardid, Reza
Publicado no J Med Phys (2015)
“...-sensitivity of peripheral blood mononucleated cells (PBMCs) was measured by the Bcl-2/BAX ratio (as a...”Publicado no J Med Phys (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Wafa, Abdulsamad, Moassass, Faten, Liehr, Thomas, Bhatt, Samarth, Aljapawe, Abdulmunim, Al Achkar, Walid
Publicado no Mol Cytogenet (2016)
Assuntos:
“...Case Report...”Publicado no Mol Cytogenet (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Magnoli, Francesca, Tibiletti, Maria Grazia, Uccella, Silvia
Publicado no Front Med (Lausanne) (2019)
“... entities, encompassing a variegated and complex genetic background. This has led to the inclusion...”Publicado no Front Med (Lausanne) (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Al-Katib, Ayad M, Sun, Yuan, Goustin, Anton Scott, Azmi, Asfar Sohail, Chen, Ben, Aboukameel, Amro, Mohammad, Ramzi M
Publicado em 2009
“... strategy for treating B-cell tumors. We evaluated the efficacy of TW-37, a non-peptidic SMI of Bcl-2...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Schiefer, Ana-Iris, Kornauth, Christoph, Simonitsch-Klupp, Ingrid, Skrabs, Cathrin, Masel, Eva Katharina, Streubel, Berthold, Vanura, Katrina, Walter, Karin, Migschitz, Brigitta, Stoiber, Dagmar, Sexl, Veronika, Raderer, Markus, Chott, Andreas, da Silva, Maria Gomes, Cabecadas, Jose, Müllauer, Leonhard, Jäger, Ulrich, Porpaczy, Edit
Publicado no Medicine (Baltimore) (2015)
“...MYC and BCL2 translocations as well as TP53 deletion/mutation are known risk factors in diffuse...”Publicado no Medicine (Baltimore) (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Ning, Yi, Foss, Aubry, Kimball, Amy S, Neill, Nicholas, Matz, Tricia, Schultz, Roger
Publicado em 2013
Assuntos:
“...Case Report...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Publicado em 2013
“... comprising a total of 15,317 cases and 29,529 controls. The distribution of nominally significant loci...”Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
“... of apoptosis-related proteins (FasL, Fas, Bax, Bcl-2), apoptotic cells, inflammatory cytokines [tumour necrosis...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo